Biomarkers in the emergency workup of chest pain: uses, limitations, and future
Wassim Mosleh1, Husam Abdel-Qadir, Michael Farkouh
1Trinity College, Dublin, Ireland.
Insights
Cardiac biomarkers are crucial for diagnosing acute coronary syndromes in patients with chest pain. Combined with other clinical data, they help predict adverse outcomes.
Area of Science:
- Cardiology
- Clinical Diagnostics
Background:
- Chest pain is a common presenting symptom requiring accurate diagnosis.
- Acute coronary syndromes (ACS) are a critical concern in patients with chest pain.
- Cardiac biomarkers play a role in assessing ACS risk.
Purpose of the Study:
- To emphasize the importance of cardiac biomarkers in the diagnostic workup of chest pain.
- To highlight the integration of biomarker data with other clinical findings.
Main Methods:
- Review of clinical presentation of chest pain.
- Integration of patient history, physical examination, and electrocardiography (ECG).
- Analysis of cardiac biomarker levels.
Main Results:
- Cardiac biomarker levels are one component of the overall clinical assessment.
- These levels, alongside other data, aid in probability estimation for ACS.
- Biomarker data contributes to predicting adverse clinical outcomes.
Conclusions:
- Cardiac biomarkers are essential but not solely determinative in diagnosing ACS.
- A comprehensive approach integrating biomarkers with clinical evaluation is necessary.
- Accurate assessment aids in timely and appropriate patient management.
Abstract:
When patients present with chest pain, their levels of cardiac biomarkers are only one piece of the clinical picture, albeit an important one. Together with the history, physical examination, and electrocardiography (ECG), these levels help estimate the probability that the patient is experiencing an acute coronary syndrome and will have an adverse clinical outcome.
More Related Videos
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Angina III: Clinical Manifestations and Assessment
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome I: Introduction
Angina V: Nursing Management
